These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1021462)

  • 21. Immunoconglutinins and C3 in human saliva.
    Williams BD; Challacombe SJ; Slaney JM; Lachmann PJ; Lehner T
    Clin Exp Immunol; 1975 Mar; 19(3):423-33. PubMed ID: 1239346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. So you suspect systemic lupus erythematosus: which test to perform?
    Urowitz MB
    Int J Dermatol; 1982 Dec; 21(10):592-3. PubMed ID: 7160949
    [No Abstract]   [Full Text] [Related]  

  • 24. Correlations between anti-dsDNA antibodies, complement levels and clinical course in SLE patients treated with steroid pulse therapy.
    Pioltelli P; Procaccio F; Invernizzi F; Ponticelli C; Tarantino A
    Boll Ist Sieroter Milan; 1978 Sep; 57(4):485-9. PubMed ID: 737041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Observation of the third component of complement (C3) and total hemolytic complement (CH50) in serum with SLE].
    Jin A; Chen P; Ke X; Yu M; Fan L; Zhang N; Hou J; Ling Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Oct; 4(5):322-3. PubMed ID: 6219771
    [No Abstract]   [Full Text] [Related]  

  • 26. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of in vivo-bound immunoglobulins and complement in the skin of systemic lupus erythematosus patients.
    Deng JS; Lin RY; Lu YC
    J Dermatol; 1976 Oct; 3(5):237-40. PubMed ID: 798742
    [No Abstract]   [Full Text] [Related]  

  • 28. [Changes of renal histological findings, serum C3, C4 level in patients with lupus nephritis by steroid therapy].
    Sueishi M; Tomioka H; Yanagisawa T; Nawata Y; Kagami M; Koike T; Takabayashi K; Yoshida S; Kumagai A; Tsuchida H
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):343-52. PubMed ID: 6471579
    [No Abstract]   [Full Text] [Related]  

  • 29. C3 activation products correlate with antibodies to lipid A in pauciarticular juvenile arthritis.
    Olds LC; Miller JJ
    Arthritis Rheum; 1990 Apr; 33(4):520-4. PubMed ID: 2328030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relation between various autoimmune antibodies and serum complement levels in patients with systemic lupus erythematosus].
    Okumura N; Kumagai T; Kameko M; Kanai M
    Rinsho Byori; 1986 Aug; 34(8):967-72. PubMed ID: 3784036
    [No Abstract]   [Full Text] [Related]  

  • 31. A new enzyme-linked immunosorbent assay (ELISA) for measuring immunoconglutinins directed against the third component of human complement. Findings in systemic lupus erythematosus.
    Durand CG; Burge JJ
    J Immunol Methods; 1984 Oct; 73(1):57-66. PubMed ID: 6491304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Plasma level of complement fractions C3 and C4 in children with glomerular nephropathies. Correlations with morphological and immunopathological studies of renal biopsies].
    Loirat C; Levy M
    Arch Fr Pediatr; 1976 Nov; 33(G):853-72. PubMed ID: 827270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of serum complement in the hypocomplementaemic nephritides.
    Williams DG; Peters DK; Fallows J; Petrie A; Kourilsky O; Morel-Maroger L; Cameron JS
    Clin Exp Immunol; 1974 Nov; 18(3):391-405. PubMed ID: 4219908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and characterization of IgG immunoconglutinins from patients with systemic lupus erythematosus: implications for a regulatory function.
    Nilsson B; Ekdahl KN; Svarvare M; Bjelle A; Nilsson UR
    Clin Exp Immunol; 1990 Nov; 82(2):262-7. PubMed ID: 2146995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of B-lymphocytes with receptors to C3 component of complement in patients with glomerulonephritis and systemic lupus erythematosus].
    Gordovskaia NB; Bulanova TD; Traianova TG
    Ter Arkh; 1977; 49(7):45-50. PubMed ID: 331546
    [No Abstract]   [Full Text] [Related]  

  • 37. Modulation of complement by autoimmune antibodies isolated from sera of patients with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
    Daha MR; Van Es LA
    Neth J Med; 1982; 25(7):202-7. PubMed ID: 6924073
    [No Abstract]   [Full Text] [Related]  

  • 38. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement system and small HDL particles are associated with subclinical atherosclerosis in SLE patients.
    Parra S; Vives G; Ferré R; González M; Guardiola M; Ribalta J; Castro A
    Atherosclerosis; 2012 Nov; 225(1):224-30. PubMed ID: 23031360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening test for complement activation by counterimmunoelectrophoresis.
    Arroyave CM; Taylor DG; Gallup P; Nakamura RM
    Am J Clin Pathol; 1978 Apr; 69(4):440-5. PubMed ID: 417620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.